Filing Details
- Accession Number:
- 0001209191-18-021928
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-28 16:37:28
- Reporting Period:
- 2018-03-26
- Accepted Time:
- 2018-03-28 16:37:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035354 | Eloxx Pharmaceuticals Inc. | ELOX | Services-Commercial Physical & Biological Research (8731) | 841368850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726049 | Zafrira Avnur | C/O Eloxx Pharmaceuticals, Inc. 950 Winter Street, 4Th Floor North Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-26 | 2,000 | $9.49 | 2,263 | No | 4 | P | Indirect | By: Spouse's IRA |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By: Spouse's IRA |
Billionaire Hedge Funds
